Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis

Limitations of subgroup analysis of underpowered clinical trials for making causal inference about treatment effects

(2020) Milad Nazarzadeh et al.   EUROPEAN HEART JOURNAL

Investigating the stratified efficacy and safety of pharmacological blood pressure-lowering: an overall protocol for individual patient-level data meta-analyses of over 300 000 randomised participants in the new phase of the Blood Pressure Lowering Treatment Trialists’ Collaboration (BPLTTC)

(2019) Kazem Rahimi et al.   BMJ Open

Eligibility and subsequent burden of cardiovascular disease of four strategies for blood pressure-lowering treatment: a retrospective cohort study

(2019) Emily Herrett et al.   LANCET

Long‐Term Exposure to Elevated Systolic Blood Pressure in Predicting Incident Cardiovascular Disease: Evidence From Large‐Scale Routine Electronic Health Records

(2019) Jose Roberto Ayala Solares et al.   Journal of the American Heart Association

Systolic Blood Pressure and Risk of Valvular Heart Disease

(2019) Milad Nazarzadeh et al.   JAMA Cardiology

2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults

(2018) Paul K. Whelton et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: A meta-analysis of individual participant data

(2018) Kunal N. Karmali et al.   PLOS MEDICINE

Association of Blood Pressure Lowering With Mortality and Cardiovascular Disease Across Blood Pressure Levels

(2018) Mattias Brunström et al.   JAMA Internal Medicine

2018 ESC/ESH Guidelines for the management of arterial hypertension

(2018) Bryan Williams et al.   EUROPEAN HEART JOURNAL

Elevated blood pressure and risk of aortic valve disease: a cohort analysis of 5.4 million UK adults

(2018) Kazem Rahimi et al.   EUROPEAN HEART JOURNAL

Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials

(2017) Michael Böhm et al.   LANCET

Elevated blood pressure and risk of mitral regurgitation: A longitudinal cohort study of 5.5 million United Kingdom adults

(2017) Kazem Rahimi et al.   PLOS MEDICINE

Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study

(2016) Emmanuelle Vidal-Petiot et al.   LANCET

Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis

(2016) Dena Ettehad et al.   LANCET

Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease

(2016) Eva M. Lonn et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effects of Blood Pressure Reduction in Mild Hypertension

(2015) Johan Sundström et al.   ANNALS OF INTERNAL MEDICINE

The Epidemiology of Blood Pressure and Its Worldwide Management

(2015) K. Rahimi et al.   CIRCULATION RESEARCH

Effect of antihypertensive agents on risk of atrial fibrillation: a meta-analysis of large-scale randomized trials

(2015) C. A. Emdin et al.   EUROPACE

Usual Blood Pressure and Risk of New-Onset Diabetes

(2015) Connor A. Emdin et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

A Randomized Trial of Intensive versus Standard Blood-Pressure Control

(2015)   NEW ENGLAND JOURNAL OF MEDICINE

Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data

(2014)   LANCET

Blood Pressure Management in the 21st Century

(2013) Kazem Rahimi et al.   CIRCULATION

The J-Curve Between Blood Pressure and Coronary Artery Disease or Essential Hypertension

(2009) Franz H. Messerli et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY